Pipeline — registered trials by phase
Value of Multiple Modalities Using the Spectra WaveWriter Spinal Cord Stimulator System
— · Chronic Pain, Back Pain · Completed · est. 2019-01-09
Observation of ImageReady™ MR Conditional Pacing System in China
— · Arhythmia, Atrioventricular Heart-block, Chronic Bundle Branch or Branch Block · Completed · est. 2016-03-16
A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
— · Cardiovascular Diseases · Active Not Recruiting · est. 2024-08-01
Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology
— · Atrial Fibrillation · Completed · est. 2019-04
Common Sensing and Right Ventricular Automatic Capture (COGNATE)
— · Bradycardia, Chronotropic Incompetence · Completed · est. 2010-06
Evaluation of PCLs Using Three EUS-FNA Needles
— · Pancreatic Cystic Lesions · Completed · est. 2017-06-06
VAST - Ventricular Arrhythmia Suppression Trial
— · Tachycardia · Completed
Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
— · Venous Leg Ulcer · Completed · est. 2020-05-18
Cardiac Monitor Employee Study
— · Arrhythmias, Cardiac · Completed · est. 2019-05-23
A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NAV Ablation Catheter in the Treatment of Atrial Fibrillation
— · Atrial Fibrillation, Pulsed Field Ablation, FARAPULSE · Active Not Recruiting · est. 2027-04-01
Structure and Function of Salivary Proteins
— · Cystic Fibrosis · Completed · est. 2013-06-05
RIGHT: Rhythm ID Going Head-to-Head Trial
— · Tachycardia · Completed · est. 2009-03
Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)
— · Persistent Atrial Fibrillation · Completed · est. 2022-12-01
SpyGlass AMEA Registry
— · Biliary Stricture, Biliary Obstruction Due to Common Bile Duct Stone, Periampullary Tumor · Completed · est. 2016-09
Photoselective Vaporization of the Prostate With the GreenLight XPS™ Laser System vs TURP for the Treatment of BPH
— · Benign Prostatic Hyperplasia · Completed · est. 2014-10
Double-J PLUS Postmarket Registry Study
— · Ureter Obstruction · Completed · est. 2023-01-16
An "All-Comers" Study of the AgentTM MONORAILTM Paclitaxel-Coated PTCA Balloon Catheter Used in Real-World Clinical Practice in Chinese Patients
— · Chinese Patients Treated With Agent DCB · Completed · est. 2022-08-31
PEGASUS CRT Study: Atrial Support Study in Cardiac Resynchronization Therapy
— · Heart Failure · Completed · est. 2009-01
FAST Feasibility Study
— · Coronary Artery Disease · Completed · est. 2017-01-31
VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation
— · Chronic Pain · Completed · est. 2018-09-21
Safety and Efficacy of CryoCor™ Cryoablation for PAF
— · Atrial Fibrillation · Completed · est. 2009-03
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
— · Colorectal Cancer Metastatic · Completed · est. 2020-08-31
Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence
— · Stress Urinary Incontinence · Completed · est. 2018-01-17
AIR Extension Study - Long-Term Safety of Alair Treated Subjects
— · Asthma · Completed · est. 2009-12
Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up Study
— · Carotid Artery Disease, Carotid Stenosis, Stroke · Completed · est. 2011-06
Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)
— · Emphysema · Completed · est. 2013-06
No registered trials in this stage.
MANDARIN (S6371)
— · Inoperable Hepatocellular Carcinoma · Completed · est. 2026-02-13
Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure
— · Congestive Heart Failure · Completed
Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
— · Atrial Fibrillation, Stroke · Completed · est. 2013-01
TAXUS PERSEUS Small Vessel
— · Coronary Artery Disease · Completed · est. 2009-06
A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
— · Atherosclerosis, Coronary Artery Disease · Completed · est. 2009-09
Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence
— · Varicose Veins · Completed · est. 2011-09
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Boston Scientific is lead sponsor; 69 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-10-07Current report (material event)
- 8-K2026-09-23Current report (material event)
- 8-K2026-09-08Current report (material event)
- 8-K2026-08-26Current report (material event)
- SCHEDULE 13G/A2026-08-06SCHEDULE 13G/A
- 10-Q2026-08-03Quarterly report
- 8-K2026-07-29Current report (material event)
- 8-K2026-07-27Current report (material event)
- 11-K2026-06-2411-K
- SD2026-05-21SD
- 8-K2026-05-18Current report (material event)
- 8-K2026-05-18Current report (material event)
- S-82026-05-08Employee stock plan
- SCHEDULE 13G/A2026-05-06SCHEDULE 13G/A
- 8-K2026-05-05Current report (material event)
- 10-Q2026-05-01Quarterly report
- SCHEDULE 13G2026-04-29SCHEDULE 13G
- 4252026-04-22425
- 8-K2026-04-22Current report (material event)
- EFFECT2026-04-01EFFECT
- 424B32026-04-01424B3
- CORRESP2026-03-30CORRESP
- S-4/A2026-03-30S-4/A
- 8-K2026-03-30Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- DEFA14A2026-03-18DEFA14A
- DEF 14A2026-03-18Proxy statement
- ARS2026-03-18Annual report to holders
- UPLOAD2026-03-09UPLOAD
- PRE 14A2026-03-06PRE 14A
- 4252026-03-03425
- S-42026-02-27S-4
- 8-K2026-02-26Current report (material event)
- 8-K2026-02-23Current report (material event)
- 10-K2026-02-17Annual report
- 8-K2026-02-05Current report (material event)
- 4252026-02-04425
- 8-K2026-02-04Current report (material event)
- 4252026-01-20425
- 4252026-01-20425
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.